Trials / Terminated
TerminatedNCT00403988
Vinorelbine and Oxaliplatin (Vinox) With or Without Trastuzumab (Herceptin®) in Advanced Breast Carcinoma
A Clinical Phase II Study of Vinorelbine and Oxaliplatin (Vinox) With or Without Trastuzumab (Herceptin®) in Advanced Breast Carcinoma
- Status
- Terminated
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 40 (estimated)
- Sponsor
- American University of Beirut Medical Center · Academic / Other
- Sex
- Female
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
Study Objective : To assess the efficacy and the safety of the combination of Oxaliplatin, and Vinorelbine with or without Trastuzumab as a salvage regimen in patients with Metastatic Breast Cancer
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Oxaliplatin | |
| DRUG | vinorelbine |
Timeline
- Start date
- 2004-06-01
- Completion
- 2007-12-01
- First posted
- 2006-11-27
- Last updated
- 2008-11-04
Locations
1 site across 1 country: Lebanon
Source: ClinicalTrials.gov record NCT00403988. Inclusion in this directory is not an endorsement.